Overall Survival

Figure 5. 2-MPPA, a prototype GCP-II inhibitor, significantly prolongs FALS transgenic mice survival (delta = 29 days, a 15% increase in the mean life span, p= 0.0059)21.

Days on Study Therapy

Figure 5. 2-MPPA, a prototype GCP-II inhibitor, significantly prolongs FALS transgenic mice survival (delta = 29 days, a 15% increase in the mean life span, p= 0.0059)21.

Was this article helpful?

0 0

Post a comment